Pitofsky Jason

SVP ControllerREGENERON PHARMACEUTICALS, INC. (REGN) · full profile →Form 4 · filed Feb 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
13
12 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Sell(S)521$776.43$405K6K
Feb 9, 2026Sell(S)53$785.72$42K4K
Feb 9, 2026Sell(S)1$784.66$7854K
Feb 9, 2026Sell(S)144$783.23$113K4K
Feb 9, 2026Sell(S)37$782.67$29K4K
Feb 9, 2026Sell(S)26$781.37$20K5K
Feb 9, 2026Sell(S)75$780.06$59K5K
Feb 9, 2026Sell(S)205$779.56$160K5K
Feb 9, 2026Sell(S)563$778.35$438K5K
Feb 9, 2026Option exercise(M)1K$492.00$492K6K
Feb 9, 2026Sell(S)20$775.95$16K6K
Feb 9, 2026Sell(S)391$777.51$304K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Option exercise(M)1K$0905

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002009236-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly: